Table 1.
Demographic characteristics of the EC cohort in this study
| Variable | Elite controllers |
|---|---|
| N | 59 |
| Age a | 38 (31 to 44) |
| Sex | |
| Male | 35 (59.3%) |
| Female | 24 (40.7%) |
| Risk for HIV acquisition | |
| Parenteral | 31 (52.5%) |
| MSM | 15 (25.4%) |
| HET | 11 (18.6%) |
| Unknown | 2 (3.4%) |
| HCV | |
| Negative serology | 26 (44%) |
| Positive serology | 33 (55.9%) |
| Cured | 18 (30.5%) |
| Not cured | 15 (25.4%) |
| Baseline CD4+ T cells/mm a | 699 (544 to 864) |
| Nadir CD4+ T cells/mm a | 414 (275 to 536) |
| Zenith viral load (log10 copies/mL) b | 3.05 (0.13) |
| Years of follow‐up a | 17 (9 to 25) |
HCV, Hepatitis C Virus evaluated at baseline; HET: Heterosexual; MSM, Men who have sex with men.
a
Median (Interquartile Range)
b
mean (Standard Error).